Skip to content
Med Pharma News

Med Pharma News

Your Daily Dose of Pharma News

  • About Med Pharma News
  • Contact Us
  • News
  • Privacy Policy
  • Terms and Conditions
  • Home
  • Phase 3

Tag: Phase 3

Caplyta bipolar mania Phase 3 Study 452 results infographic
  • Pharmaceuticals

Caplyta Bipolar Mania: Second Phase 3 Win Sets Up J&J FDA Filing

Megan Wood2 weeks ago09 mins

J&J’s Caplyta (lumateperone) beat placebo in Study 452, its second pivotal Phase 3 trial in bipolar I mania, clearing the way for an FDA filing. Here is how the two studies compare.

Read More
Envudeucitinib plaque psoriasis: 54% PASI 100 at week 48, scalp, itch and quality of life milestones
  • Pharmaceuticals

Alumis Reports 48-Week Phase 3 Data for Envudeucitinib in Plaque Psoriasis

Megan Wood1 month ago1 month ago011 mins

Envudeucitinib plaque psoriasis: Alumis reports 54% complete skin clearance at 48 weeks in Phase 3 ONWARD3 and plans an NDA in Q4 2026.

Read More
AnnJi AJ201 Phase 3 ROMA-KD Kennedy disease trial featured graphic
  • Pharmaceuticals

AnnJi Advances AJ201 into Phase 3 Trial for Kennedy’s Disease

Megan Wood2 months ago1 month ago011 mins

AJ201 (rosolutamide) moves into the pivotal Phase 3 ROMA-KD trial for Kennedy disease, or SBMA. Mechanism, earlier data and what is unknown.

Read More

Categories

  • Healthcare IT (26)
  • Industry Insights (370)
  • Lifestyle and Wellness (24)
  • Medical Devices (45)
  • Pharmaceuticals (116)
  • Uncategorized (1)

Recent Posts

  • Roundup Settlement Approved: How Bayer’s $7.25B Cancer Deal Pays Out
  • Novo Nordisk Layoffs: 215 More Jobs Cut at US Headquarters in Sales Overhaul
  • MAHA ELEVATE Model: CMS Awards $47M to 15 Groups to Test Lifestyle Medicine in Medicare
  • Rasonque EU Approval: Daraxonrasib Becomes Europe’s First RAS Pill for Pancreatic Cancer
  • Barzolvolimab Atopic Dermatitis Trial Fails: Celldex Drops Eczema to Focus on Hives
Digital Newspaper - Multipurpose News WordPress Theme 2026. Powered By BlazeThemes.